Financials
Financial year 2026
Worth noting
- A loss two years in a row.
- Figures corrected afterwards (2021).
Gross margin
€ 1.6 million
▲ 77% vs 2025
Profit
Caution€ -380,057
▲ 28% vs 2025
Debts
Low€ 661,069
▼ 48% vs 2025
ADx NeuroSciences from Gent, company number BE0839400980, closed financial year 2026 with a result of € -380,057 after tax. For that financial year ADx NeuroSciences recorded a gross margin of € 1.6 million and equity of € 4.2 million. Compared with financial year 2025, the result moved from € -525,119 to € -380,057. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
What happened at ADx NeuroSciences?
What happened at ADx NeuroSciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 380,057. Source: NBB ↗
- KDIV Consult stepped down as director. NBB
- Goki Ishikawa stepped down as director. NBB
- Tadashi Ninomiya became a director. NBB
- Kurt Troch became a director. NBB
- Koji Aoki became a director. NBB
- CDW Invest became a director. NBB
- Goki Ishikawa became a director. NBB
In short
From € 938,618 profit in 2021 to € 380,057 loss in 2026.
Paid € 79,885 in corporate taxes since 2021.
Best year ever: 2023, with € 1.4 million profit.
On average € 86,000 of value added per employee in 2026.
A new publication or filing at ADx NeuroSciences? We notify you, reason included.
Follow ADx NeuroSciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ADx NeuroSciences are Tadashi Ninomiya, Kurt Troch, Koji Aoki and CDW Invest. The same people are also behind FUJIREBIO EUROPE.
Directors
According to the 2026 annual accounts
Tadashi Ninomiya
Director
since 2026
Kurt Troch
Director
since 2026
Koji Aoki
Director
since 2022
since 2022
Managing director · represented by Koen Dewaele
since 2012 · until 2026
Goki Ishikawa
Director
since 2022 · until 2026
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 6
9052 Gent
Technologiepark-Zwijnaarde 94
9052 Gent
Active since 19 September 2011
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
adxneurosciences.com
Registered
2011-06-25
Registrar
Ascio Technologies, Inc
Expires
2026-06-25
Website info
Features
Security
Network
Details
- Company number
- 0839.400.980
- VAT number
- BE 0839.400.980
- Registered office
- Technologiepark-Zwijnaarde 6, 9052 Gent
- Names & denominations
- ADx NeuroSciences
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 September 2011
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- adxneurosciences.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied